Vinflunine in the treatment of bladder cancer

References

• Advanced Bladder Cancer Meta-analysis Collaboration2003Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisLancet36119273412801735
   PubMed Web of Science ®Google Scholar
• Advanced Bladder Cancer Meta-analysis Collaboration2005aAdjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis CollaborationEur Urol4818999 discussion 199–201
   PubMed Web of Science ®Google Scholar
• Advanced Bladder Cancer Meta-analysis Collaboration2005bNeoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaborationEur Urol482025 discussion 205–6
   PubMed Web of Science ®Google Scholar
• AlbersPSienerRHartleinM2002Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma – prognostic factors for response and improvement of quality of lifeOnkologie25475211893883
   PubMedGoogle Scholar
• AlbersPSienerRParkS2008Randomized phase III trial of 2nd line gemcitabine/paclitaxel chemotherapy in patients with advanced bladder cancer: Temporary versus maintenance treatment (German Association of Urologic Oncology (AUO) Trial AB 20/99)J Clin Oncol2620 Suppl Abstr 5030
   PubMedGoogle Scholar
• BaguleyBCHoldawayKMThomsenLL1991Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanismEur J Cancer2748271827725
   PubMed Web of Science ®Google Scholar
• BajorinDFDoddPMMazumdarM1999Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapyJ Clin Oncol1731738110506615
   PubMed Web of Science ®Google Scholar
• BarretJMEtievantCHillBT2000In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugsCancer Chemother Pharmacol45471610854134
   PubMed Web of Science ®Google Scholar
• BassiPFerranteGDPiazzaN1999Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohortJ Urol1611494710210380
   PubMed Web of Science ®Google Scholar
• BellmuntJCosJCleriesR2002Feasibility trial of methotrexatepaclitaxel as a second line therapy in advanced urothelial cancerCancer Invest206738512197223
   PubMed Web of Science ®Google Scholar
• BellmuntJDelgadoFMGeorgeC2008Clinical Activity of Vinflunine in Transitional Cell Carcinoma of the Urothelium and Other Solid TumorsSemin Oncol35S34S4318538178
   PubMed Web of Science ®Google Scholar
• Bellmunt MolinsJvon der MaaseHTheodoreC2008Randomised phase III trial of vinflunine (V) plus best supportive care (B) vs B alone as 2nd line therapy after a platinum-containing regimen in advanced transitional cell carcinoma of the urothelium (TCCU)J Clin Oncol2620 Suppl Abstr 5028
   Google Scholar
• BennounaJFumoleauPArmandJP2003Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursAnn Oncol14630712649112
   PubMed Web of Science ®Google Scholar
• BennounaJVermorkenJBSenellartH2008Phase I dose-escalation study of oral vinflunine given twice a day for 2 consecutive days every week in patients with solid tumoursJ Clin Oncol2620 Suppl Abstr 13555
   Google Scholar
• BonfilRDRussoDMBindaMM2002Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladderUrol Oncol71596612474532
   PubMed Web of Science ®Google Scholar
• BraguerDBarretJMMcDaidH2008Antitumor Activity of Vinflunine: Effector Pathways and Potential for SynergiesSemin Oncol35S13S2118538174
   PubMed Web of Science ®Google Scholar
• BunnPAJrKellyK1998New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directionsClin Cancer Res410871009607565
   PubMed Web of Science ®Google Scholar
• ChenACHoveyESheltonG2004Phase I/II study of docetaxel (D), gemcitabine (G), Carboplatin (C) in poor prognosis and previously treated patients (pts) with urothelial carcinoma (UTC)J Clin Oncol22 2004. ASCO Annual Meeting Proceedings (Post-Meeting Edition) 14S (July 15 Supplement)4580
   Web of Science ®Google Scholar
• CulineSTheodoreCDe SantisM2006A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimenBr J Cancer94139540116622447
   PubMed Web of Science ®Google Scholar
• CulineS2002The present and future of combination chemotherapy in bladder cancerSemin Oncol2932912094336
   PubMed Web of Science ®Google Scholar
• DalbagniGGenegaEHashibeM2001Cystectomy for bladder cancer: a contemporary seriesJ Urol1651111611257649
   PubMed Web of Science ®Google Scholar
• De MulderPHTheodoreCSellaA2000Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractAnn Oncol111391411142477
   PubMed Web of Science ®Google Scholar
• DelordJPStuppRPinelMC2001Phase I Study of vinflunine given as a 10 minute intravenous (iv) Infusion on a weekly schedule in patients (pts) with advanced solid tumoursProc Am Soc Clin Oncol202001 (Abstr 441)
   Google Scholar
• DoddPMMcCaffreyJAMazumdarM2000Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinomaInvest New Drugs182475110958593
   PubMed Web of Science ®Google Scholar
• DreicerRLiSManolaJ2007Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800): a trial of the Eastern Cooperative Oncology GroupCancer1107596317594721
   PubMed Web of Science ®Google Scholar
• EtievantCBarretJMKruczynskiA1998Vinflunine (20’,20’-difluoro-3’,4’-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitroInvest New Drugs163179740539
   PubMed Web of Science ®Google Scholar
• EtievantCKruczynskiABarretJM2001Markedly diminished drug resistance-inducing properties of vinflunine (20’,20’-difluoro-3’, 4’-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitroCancer Chemother Pharmacol48627011488526
   PubMed Web of Science ®Google Scholar
• FabreCCzaplickiJWrightM2002Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analysesBiochem Pharmacol647334012167492
   PubMed Web of Science ®Google Scholar
• FahyJDuflosARibetJP1997Vinca Alkaloids in Superacidic Media: A Method for Creating a New Family of Antitumor DerivativesJ Am Chem Soc11985767
   Web of Science ®Google Scholar
• FahyJHellierPBreilloutF2008Vinflunine: discovery and synthesis of a novel microtubule inhibitorSemin Oncol35S3S518538177
   PubMed Web of Science ®Google Scholar
• FechnerGSienerRReimannM2006Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99)Int J Clin Pract60273116409425
   PubMed Web of Science ®Google Scholar
• FocanCNVan HeugenJ-CKreutzF2002Vinflunine metabolism and disposition in cancer patientsProc Am Soc Clin Oncol21 abstr 495
   Google Scholar
• GalskyMDMironovSIasonosA2007Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinomaInvest New Drugs252657017146733
   PubMed Web of Science ®Google Scholar
• GebbiaVTestaABorsellinoN1999Single agent 2’, 2’-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II studyClin Ter15011510367539
   PubMedGoogle Scholar
• GhoneimMAel-MekreshMMel-BazMA1997Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 casesJ Urol15839399224310
   PubMed Web of Science ®Google Scholar
• GoutPWNobleRLBruchovskyN1984Vinblastine and vincristine–growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cellsInt J Cancer3424586469399
   PubMed Web of Science ®Google Scholar
• GregoryRKSmithIE2000Vinorelbine – a clinical reviewBr J Cancer8219071310864196
   PubMed Web of Science ®Google Scholar
• HillBTFiebigHHWaudWR1999Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenograftsEur J Cancer355122010448309
   PubMed Web of Science ®Google Scholar
• HillBT2001Vinflunine, a second generation novel vinca alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockersCurr Pharm Des7119921211472262
   PubMed Web of Science ®Google Scholar
• HillSALonerganSJDenekampJ1993Vinca alkaloids: anti-vascular effects in a murine tumourEur J Cancer29A132048343277
   PubMed Web of Science ®Google Scholar
• HolwellSEHillBTBibbyMC2001Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma modelBr J Cancer84290511161390
   PubMed Web of Science ®Google Scholar
• HortobagyiGN2000Developments in chemotherapy of breast cancerCancer883073910898354
   PubMedGoogle Scholar
• Jean-DecosterCBricheseLBarretJM1999Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cellsAnti-cancer Drugs103743
   Web of Science ®Google Scholar
• JohnsonPGeldartTFumoleauP2006Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeksInvest New Drugs242233116211365
   PubMed Web of Science ®Google Scholar
• JohnsonPO’DonnellAPinelMC2001Phase I Study of Vinflunine Given as a 10 Minute Infusion on Days 1 and 8 Every 3 Weeks in Patients (Pts) with Solid MalignanciesProc Am Soc Clin Oncol20 Abstr 2100
   Google Scholar
• JohnsonSAHarperPHortobagyiGN1996Vinorelbine: an overviewCancer Treat Rev22127428665565
   PubMed Web of Science ®Google Scholar
• JolyFTchenNChevreauC2004Clinical benefit of second line weekly paclitaxel in advanced urothelial carcinoma (AUC): A GETUG phase II studyJ Clin Oncol22 2004. ASCO Annual Meeting Proceedings (Post-Meeting Edition) 14S (July 15 Supplement)4619
   Web of Science ®Google Scholar
• JordanMABand HorwitzSLobertS2008Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor VinflunineSemin Oncol35S6S1218538179
   PubMed Web of Science ®Google Scholar
• JordanMAHimesRHWilsonL1985Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitroCancer Res45274173986806
   PubMed Web of Science ®Google Scholar
• JordanMAThrowerDWilsonL1991Mechanism of inhibition of cell proliferation by Vinca alkaloidsCancer Res512212222009540
   PubMed Web of Science ®Google Scholar
• KaufmanDStadlerWCarducciM2000Gemcitabine (G) and Paclitaxel (P) Every Two Weeks (GP2W): A Multicenter Phase II Trial in Locally Advanced or Metastatic Urothelial Cancer (UC)Proc Am Soc Clin Oncol19 Abstr 1341
   Google Scholar
• KavallarisMAnnereauJ-PBarretJ-M2008Potential Mechanisms of Resistance to Microtubule InhibitorsSemin Oncol35S22S2718538175
   PubMed Web of Science ®Google Scholar
• KhorsandMLangeJFeunL1997Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderInvest New Drugs15157639220296
   PubMed Web of Science ®Google Scholar
• KregeSRembrinkVBorgermannC2001Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 studyJ Urol165677111125366
   PubMed Web of Science ®Google Scholar
• KruczynskiABarretJMEtievantC1998aAntimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated vinca alkaloidBiochem Pharmacol55635489515574
   PubMed Web of Science ®Google Scholar
• KruczynskiAColpaertFTarayreJP1998bPreclinical in vivo antitumor activity of vinflunine, a novel fluorinated vinca alkaloidCancer Chemother Pharmacol41437479554586
   PubMed Web of Science ®Google Scholar
• KruczynskiAEtievantCPerrinD2002Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical developmentBr J Cancer861435011857026
   PubMed Web of Science ®Google Scholar
• Le ChevalierTBrisgandDDouillardJY1994Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsJ Clin Oncol1236078113844
   PubMed Web of Science ®Google Scholar
• LemarieEBennounaJGrossiF2005Vinflunine (VFL) in combination with gemcitabine (GEM) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Preliminary results of the phase I and pharmacokinetic studyJ Clin Oncol23 2005. ASCO Annual Meeting Proceedings (Post-Meeting Edition) 16S (July 15 Suppl)7266
   Google Scholar
• LinCCHsuCHHuangCY2007Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II studyAnticancer Drugs184879117351402
   PubMed Web of Science ®Google Scholar
• LobertSPuozzoC2008Pharmacokinetics, metabolites, and preclinical safety of vinflunineSemin Oncol35S28S3318538176
   PubMed Web of Science ®Google Scholar
• LobertSIngramJWHillBT1998A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocityMol Pharmacol53908159584218
   PubMed Web of Science ®Google Scholar
• LoehrerPJSrEinhornLHElsonPJ1992A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyJ Clin Oncol101066731607913
   PubMed Web of Science ®Google Scholar
• LogothetisCJDieringerPEllerhorstJ1992A 61% response rate with 5-fluorouracil, interferon-a 2b and cisplatin in metastatic chemotherapy refractory transitional cell carcinomaProc Am Assoc Cancer Res33221
   Google Scholar
• LorussoVPolleraCFAntimiM1998A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerEur J Cancer341208129849481
   PubMed Web of Science ®Google Scholar
• McCaffreyJAHiltonSMazumdarM1997Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ Clin Oncol15185379164195
   PubMed Web of Science ®Google Scholar
• MeluchAAGrecoFABurrisHA3rd2001Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research networkJ Clin Oncol1930182411408496
   PubMed Web of Science ®Google Scholar
• MooreMWinquistEVokesE2003Phase II study of oxaliplatin in patients with inoperable, locally advanced or metastatic transitional cell carcinoma of the urothelial tract (TCC) who have received prior chemotherapyProc Am Soc Clin Oncol22 Abstr 1638
   Google Scholar
• NganVKBellmanKHillBT2001Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunineMol Pharmacol602253211408618
   PubMed Web of Science ®Google Scholar
• NganVKBellmanKPandaD2000Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubulesCancer Res6050455111016627
   PubMed Web of Science ®Google Scholar
• PagliaroLCMillikanRETuSM2002Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaJ Clin Oncol2029657012089226
   PubMed Web of Science ®Google Scholar
• PapamichaelDGallagherCJOliverRT1997Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureterBr J Cancer7560679052419
   PubMed Web of Science ®Google Scholar
• ParidaensRWildiersHDalencF2007Vinflunine in combination with trastuzumab for treatment of HER2-positive metastatic breast cancerJ Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No 18S (June 20 Supplement): 20071058
   Web of Science ®Google Scholar
• ParkinDMBrayFFerlayJ2005Global cancer statistics, 2002CA Cancer J Clin557410815761078
   PubMed Web of Science ®Google Scholar
• PauleBSalibaFGil-DelgadoM2007Phase I and pharmacokinetic (PK) dose-adjusted study of IV vinflunine (VFL) in cancer patients with liver dysfunction (LD): Pharmacokinetic resultsJ Clin Oncol25 2007. ASCO Annual Meeting Proceedings 25(18S) (June 20 Suppl)2523
   Web of Science ®Google Scholar
• PourroyBCarreMHonoreS2004Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathwayMol Pharmacol665809115322250
   PubMed Web of Science ®Google Scholar
• PronzatoPViganiAPensaF1997Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancerAm J Clin Oncol20519219345341
   PubMed Web of Science ®Google Scholar
• PuozzoCVermorkenJBBauerJ2001A Phase I Pharmacokinetic Study of Vinflunine Given on a Weekly ScheduleProc Am Soc Clin Oncol20 Abstr 2107
   Google Scholar
• RamlauRSouquetP-JSunX2004Results of a phase I/II and pharmacokinetic study of vinflunine (VFL) in combination with cisplatin (CDDP) for primary treatment of advanced non-small cell lung cancer (NSCLC)J Clin Oncol22 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) (14S) (July 15 Suppl)7110
   Web of Science ®Google Scholar
• RosenbergJECarrollPRSmallEJ2005Update on chemotherapy for advanced bladder cancerJ Urol174142015947569
   PubMed Web of Science ®Google Scholar
• RothBJManolaJDreicerR2002Piritrexim in advanced, refractory carcinoma of the urothelium (E3896): a phase II trial of the Eastern Cooperative Oncology GroupInvest New Drugs20425912448661
   PubMed Web of Science ®Google Scholar
• SalibaFPauleBAdamR2007Vinflunine in patients with advanced unresectable hepatocellular carcinoma and liver impairmentJ Clin Oncol25 2007 ASCO Annual Meeting Proceedings (18S) (June 20 Suppl)15023
   Web of Science ®Google Scholar
• ShahUSanoffHKO’NeilBH2008A phase I trial of pemetrexed and vinflunine (VFL)J Clin Oncol26 (May 20 Suppl):Abstr 13508
   Web of Science ®Google Scholar
• Singer WDandHimesRH1992Cellular uptake and tubulin binding properties of four Vinca alkaloidsBiochem Pharmacol43545511540212
   PubMed Web of Science ®Google Scholar
• SridharSSStadlerWLeL2005Phase 2 study of Bortezomib in Advanced or Metastatic Urothelial Cancer. A trial of the Princess Margaret Hospital [PMH] Phase II ConsortiumJ Clin Oncol23 ASCO Annual Meeting Proceedings (16S, Part I of II)(June 1 Suppl)4677
   Web of Science ®Google Scholar
• SteinJPLieskovskyGCoteR2001Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patientsJ Clin Oncol196667511157016
   PubMed Web of Science ®Google Scholar
• SteinJP2006Improving outcomes with radical cystectomy for high-grade invasive bladder cancerWorld J Urol245091617009051
   PubMed Web of Science ®Google Scholar
• SternbergCNVogelzangNJ2003Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancersCrit Rev Oncol Hematol46SupplS1051512850531
   PubMed Web of Science ®Google Scholar
• SternbergCNCalabroFPizzocaroG2001Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapyCancer922993811753976
   PubMed Web of Science ®Google Scholar
• SternbergCNYagodaAScherHI1988M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urotheliumJ Urol13946193343727
   PubMed Web of Science ®Google Scholar
• SweeneyCJRothBJKabbinavarFF2006Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urotheliumJ Clin Oncol243451716849761
   PubMed Web of Science ®Google Scholar
• SweeneyCJWilliamsSDFinchDE1999A Phase II study of paclitaxel and ifosfamide for patients with advanced refractory carcinoma of the urotheliumCancer86514810430261
   PubMed Web of Science ®Google Scholar
• TouraniJPinelMPlanchardD2005Phase I and pharmacokinetic study of Vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Final resultsJ Clin Oncol23 ASCO Annual Meeting Proceedings (16S, Part I of II) (June 1 Suppl)7271
   Google Scholar
• TuSMHossanEAmatoR1995Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignanciesJ Urol1541719227563331
   PubMed Web of Science ®Google Scholar
• VaishampayanUNFaulknerJRSmallEJ2005Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group studyCancer10416273216138364
   PubMed Web of Science ®Google Scholar
• VaughnDJBroomeCMHussainM2002Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancerJ Clin Oncol209374011844814
   PubMed Web of Science ®Google Scholar
• VaughnDJSrinivasSPetrylakDP2008Vinflunine (VFL) in patients with platinum-refractory transitional cell carcinoma of the urothelium (TCCU): results of a large phase 2 study2008ASCO Genitourinary Cancers Symposium Abstr 316
   Google Scholar
• VermorkenJBStuppRNguyenL2003Phase I Study of IV vinflunine given on a weekly schedule in previously untreated patients (pts) with advanced solid tumorsProc Am Soc Clin Oncol22 Abstr 887
   Google Scholar
• von der MaaseHHansenSWRobertsJT2000Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III studyJ Clin Oncol1830687711001674
   PubMed Web of Science ®Google Scholar
• WinquistEKirchnerTSSegalR2004Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysisJ Urol171561914713760
   PubMed Web of Science ®Google Scholar
• WitteRSElsonPBonoB1997Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinomaJ Clin Oncol15589939053481
   PubMed Web of Science ®Google Scholar
• WitteRSManolaJBurchPA1998Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trialInvest New Drugs1619159848585
   PubMed Web of Science ®Google Scholar
• WülfingCMachielsJRichelD2005A single arm, multicenter, open-label, ph II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tractJ Clin Oncol23 ASCO Annual Meeting Proceedings. (16S, Part I of II) (June 1 Suppl)4594
   Web of Science ®Google Scholar
• ZorzaGJohnsonPJudsonI2001A Phase I Pharmacokinetic Study of Vinflunine Given on Days 1 and 8 Every 3 WeeksProc Am Soc Clin Oncol20 Abstr 2070
   Google Scholar